BSI's Bos wants balanced view of Dagmar's high-risk proposals
This article was originally published in Clinica
When it comes to the regulation of medical devices in the EU, the way forward certainly does not lie in market approval by a central government agency and by currently non-existing government agencies recognizing each other’s work in a decentralized market approval mechanism.
You may also be interested in...
Where are the biggest challenges for notified bodies and manufacturers now there is some experience with the MDR, and can the sector manage the new regulatory requirements successfully?
The European Commission has finally published detailed guidance on the EU IVDR’s classification rules. The IVDR’s completely new classification regime means guidance is urgently needed.
Do you know how to avoid the pitfalls when it comes to clinical evidence under the MDR? Or whether evidence gathered outside the US counts? Amie Smirthwaite of Maetrics answers these and other pivotal questions in this third and final part of an interview series with Medtech Insight.